References
- 2016. SAMMSON long noncoding RNA Is essential for melanoma cell viability. Cancer Discov.
- Balcin O, Ak Aksoy S, Tunca B, Kaya E, Egeli U, Tezcan G, Ugras N, Cecener G, Isik O, Dundar HZ, Yerci O. 2018. Overexpression of the long noncoding RNA homeoboxa transcript at the distal tip predicts poor prognosis in a KRAS-independent manner in periampullary Region Tumors. Pancreas. 47(2):213–220. doi: https://doi.org/10.1097/MPA.0000000000000984
- Beltrami CM, Dos Reis MB, Barros-Filho MC, Marchi FA, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR. 2017. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas. Clin Epigenetics. 9:45. doi: https://doi.org/10.1186/s13148-017-0346-2
- Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu DY, Tang CJ, De W, Yang F. 2018. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 17(1):6. doi: https://doi.org/10.1186/s12943-017-0756-y
- Ding J, Wang F, Xiang T, Qiao M. 2018. Expression and function of long noncoding RNA NONHSAT129183 in papillary thyroid cancer. Oncol Res. 26(7):1047–1053. doi: https://doi.org/10.3727/096504018X15152037713570
- Giusti M, Mittica M, Comite P, Campana C, Gay S, Mussap M. 2018. Anti-mullerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer. Endocrine. 60(3):516–523. doi: https://doi.org/10.1007/s12020-017-1510-3
- Goding CR. 2016. Targeting the lncRNA SAMMSON reveals metabolic vulnerability in melanoma. Cancer Cell. 29(5):619–621. doi: https://doi.org/10.1016/j.ccell.2016.04.010
- Hao XS, Hao JH, Liu FT, Newland AC, Jia L. 2003. Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis. Apoptosis. 8(6):601–607. doi: https://doi.org/10.1023/A:1026131425204
- Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM, Ma XK, Zhu ZZ, Zhou R. 2017. LncRNA-MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor-associated macrophage FGF2 protein secretion. J Cell Biochem. 118(12):4821–4830. doi: https://doi.org/10.1002/jcb.26153
- Kwon H, Jeon MJ, Yoon JH, Hong SJ, Lee JH, Kim TY, Shong YK, Kim WB, Kim WG, Song DE. 2017. Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas. J Surg Oncol. 116(6):746–755. doi: https://doi.org/10.1002/jso.24700
- Kwon MR, Shin JH, Hahn SY, Oh YL, Kwak JY, Lee E, Lim Y. 2018. Histogram analysis of greyscale sonograms to differentiate between the subtypes of follicular variant of papillary thyroid cancer. Clin Radiol. 73(6):591 e1-591 e7. doi: https://doi.org/10.1016/j.crad.2017.12.008
- Ladurner D, Seeber G, Hofstadter F. 1984. [Papillary thyroid cancer--prognosis and prognostic factors]. Langenbecks Arch Chir. 363(1):43–55. doi: https://doi.org/10.1007/BF01255776
- Li Q, Pan X, Wang X, Jiao X, Zheng J, Li Z, Huo Y. 2017. Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma. Oncotarget. 8(63):106648–106660. doi: https://doi.org/10.18632/oncotarget.20678
- Liao X, Chen J, Liu Y, He A, Wu J, Cheng J, Zhang X, Lv Z, Wang F, Mei H. 2018. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer. Cancer Biomark. 21(2):277–285. doi: https://doi.org/10.3233/CBM-170354
- Liu N, Zhou Q, Qi YH, Wang H, Yang L, Fan QY. 2017. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis. Exp Mol Pathol. 103(1):71–77. doi: https://doi.org/10.1016/j.yexmp.2017.06.004
- Mehra R, Shi Y, Udager AM, Prensner JR, Sahu A, Iyer MK, Siddiqui J, Cao X, Wei J, Jiang H, et al. 2014. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia. 16(12):1121–1127. doi: https://doi.org/10.1016/j.neo.2014.11.006
- Shi J, Wang YJ, Sun CR, Qin B, Zhang Y, Chen G. 2017. Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma. Oncotarget. 8(64):108031–108041. doi: https://doi.org/10.18632/oncotarget.22446
- Staunton MD, Skeet RG. 1979. Thyroid cancer: prognosis in 469 patients. Br J Surg. 66(9):643–647. doi: https://doi.org/10.1002/bjs.1800660915
- Stojanovic M, Stojanovic D, Rancic N, Ignjatovic A, Antic Z, Miljkovic S, Rajovic T. 2017. Trends in thyroid cancer incidence and mortality in Central Serbia, 1999-2014. Ann Ist Super Sanita. 53(4):299–304.
- Takahashi H, Takahashi K, Shimura H, Yasumura S, Suzuki S, Ohtsuru A, Midorikawa S, Ohira T, Ohto H, Yamashita S, Kamiya K. 2017. Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer-progression model based on the national cancer registry: application to the first-round thyroid examination of the Fukushima Health Management Survey. Medicine (Baltimore). 96(48):e8631. doi: https://doi.org/10.1097/MD.0000000000008631
- Tavarelli M, Sarfati J, Chereau N, Tissier F, Golmard JL, Ghander C, Lussey-Lepoutre C, Trésallet C, Menegaux F, Leenhardt L, Buffet C. 2017. Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification. Thyroid. 27(6):778–786. doi: https://doi.org/10.1089/thy.2016.0512
- Wang CW, Lee YC, Calista E, Zhou F, Zhu H, Suzuki R, Komura D, Ishikawa S, Cheng SP. 2018. A benchmark for comparing precision medicine methods in thyroid cancer diagnosis using tissue microarrays. Bioinformatics. 34(10):1767–1773. doi: https://doi.org/10.1093/bioinformatics/btx838
- Wang P, Liu G, Xu W, Liu H, Bu Q, Sun D. 2017. Long noncoding RNA H19 inhibits cell viability, migration, and invasion via downregulation of IRS-1 in thyroid cancer cells. Technol Cancer Res Treat. 16(6):1102–1112. doi: https://doi.org/10.1177/1533034617733904
- Weeks KS, Kahl AR, Lynch CF, Charlton ME. 2018. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014. Cancer. 124(7):1483–1491. doi: https://doi.org/10.1002/cncr.31229
- Williard W, Borgen P, Bol R, Tiwari R, Osborne M. 1992. Cowden's disease. A case report with analyses at the molecular level. Cancer. 69(12):2969–2974. doi: https://doi.org/10.1002/1097-0142(19920615)69:12<2969::AID-CNCR2820691217>3.0.CO;2-2
- Xhaard C, Rubino C, Souchard V, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, et al. 2018. Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study. Cancer Epidemiol. 52:142–147. doi: https://doi.org/10.1016/j.canep.2017.12.015
- Zhai X, Xu W. 2018. Long noncoding RNA ATB Promotes proliferation, migration, and invasion in bladder cancer by suppressing MicroRNA-126. Oncol Res. 26(7):1063–1072. doi: https://doi.org/10.3727/096504018X15152072098476
- Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N. 2018. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol. 233(10):6638–6648. doi: https://doi.org/10.1002/jcp.26425
- Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G, Liang J. 2018. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep. 8(1):37. doi: https://doi.org/10.1038/s41598-017-18280-3